News Release 

Comparing major adverse cardiovascular events among patients with diabetes, reduced kidney function treated with metformin or sulfonylurea

JAMA

What The Study Did: This observational study compared major cardiovascular events (including hospitalization for heart attack, stroke, transient ischemic attack or cardiovascular death) among patients with diabetes and reduced kidney function treated with metformin or a sulfonylurea (a class of drugs to treat diabetes).

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

Authors: Christianne L. Roumie, M.D., M.P.H., of the Nashville VA Medical Center in Nashville, is the corresponding author.

(doi:10.1001/jama.2019.13206)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Media advisory: The full study and editorial are linked to this news release. This study is being released to coincide with presentation at the European Association for the Study of Diabetes annual meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.13206?guestAccessKey=cef46538-89de-4513-9868-f7178fab8a7a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091919

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.